drug
as of 2026-07-01BF2.649
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University of Texas Southwestern Medical Center
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
NCT00690274Phase 2Completed
KOLs & investigators
1
Carol A Tamminga, MDKOL score 9
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here